60
Views
8
CrossRef citations to date
0
Altmetric
Original Research

IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study

, , , &
Pages 135-142 | Published online: 05 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ana Lucia Gonzaga da Cunha, Rossana Vasconcelos, David Di Sessa, Gabriel Sampaio, Pitila Ramalhoto, Bruno F Zampieri, Bárbara S Deus, Suyan Vasconcelos, Talitha Bellote, Juiano Carvalho, Giseli Petrone, Vinicius Figueredo & Gustavo Limongi Moreira. (2023) IncobotulinumtoxinA for the Treatment of Glabella and Forehead Dynamic Lines: A Real-Life Longitudinal Case Series. Clinical, Cosmetic and Investigational Dermatology 16, pages 697-704.
Read now

Articles from other publishers (7)

Annica C. Eells, Lisa D. Grunebaum & Brittany E. Howard. (2022) Incobotulinum toxin A: A shelf‐stable, low‐molecular‐weight formulation. Dermatological Reviews 3:4, pages 211-217.
Crossref
Patrick TrevidicSimon A. ConnollyBernard BiwerBarbara Ellers-LenzLaura S. HarringtonPhilippe KestemontErnst M. NoahGerhard Sattler, Petra WeissenbergerMartina Kerscher. (2017) IncobotulinumtoxinA Is an Effective and Well-Tolerated Treatment for Upper Facial Lines: Results From an Open-Label Extension Period of a Phase III Study. Dermatologic Surgery 43:3, pages S285-S292.
Crossref
Je-Young Park, Nak-Kwan Sung & Jonathan M. Pitt. (2017) Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study. Dermatologic Surgery 43:3, pages S304-S311.
Crossref
Derek H. Jones, Martina Kerscher, Thorin Geister, Michael A. Hast & Petra Weissenberger. (2017) Efficacy of IncobotulinumtoxinA for the Treatment of Glabellar Frown Lines in Male Subjects: Post-Hoc Analyses From Randomized, Double-Blind Pivotal Studies. Dermatologic Surgery 43:2, pages S235-S241.
Crossref
JTE Lim, DK Loh, K Soh & O Sunga. (2017) Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines. Singapore Medical Journal 58:10, pages 606-609.
Crossref
Alisa A Sharova. (2016) Comparison of different consensuses of BTXA in different countries. Journal of Cosmetic Dermatology 15:4, pages 540-548.
Crossref
Martina Kerscher, Berthold Rzany, Welf Prager, Catriona Turnbull, Patrick Trevidic & Christopher Inglefield. (2015) Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines. Dermatologic Surgery 41:10, pages 1149-1157.
Crossref